With our help, our collaborators from European Biochemical Research Group are studying the use of Potassium Ribosate to mitigate the effects of Covid-19.

They have obtained very positive results in the tests carried out in the  HUCA Laboratories “Central Asturias University Hospital”

We reproduce the article published in “La Nueva España” on  21-07-2022 by  A.Lorca below.